Compare Citra Nusantara Gemilang Tbk. (CGAS) vs Cipta Sarana Medika Tbk. (DKHH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Citra Nusantara Gemilang Tbk. vs Cipta Sarana Medika Tbk. — how do they compare? Citra Nusantara Gemilang Tbk. trades at Rp153 (market cap 272.81B, 2.76M 24h volume), while Cipta Sarana Medika Tbk. trades at Rp64 (market cap 160.67B, 21.03M 24h volume). The key difference: Citra Nusantara Gemilang Tbk. is the larger of the two by market cap, and Cipta Sarana Medika Tbk. is more actively traded (21.03M versus 2.76M). Which is the better fit depends on your goals.
| CGAS | DKHH | |
|---|---|---|
Market Cap | 272.81B | 160.67B |
Volume | 2.76M | 21.03M |
Lot | 27.63K | 210.31K |
Turnover | 422.4M | 1.37B |
Average Price | 152.91 | 65.25 |
Value | 422.4M | 1.37B |
Indicative Equilibrium Price | 154 | 64 |
Indicative Equilibrium Volume | 94.2K | 1.35K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Citra Nusantara Gemilang Tbk.
PT Citra Nusantara Gemilang Tbk (the “Company”), was established based on Notarial Deed No. 22, dated December 21, 2005 of Edi Priyono, S.H.. The Company's parent entity is PT Petro Asia Energy
Read more on CGAS →About Cipta Sarana Medika Tbk.
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →
